Machina Capital S.A.S. Acquires New Holdings in Revvity Inc. $RVTY

Machina Capital S.A.S. bought a new position in Revvity Inc. (NYSE:RVTY) in the third quarter, HoldingsChannel.com reports. The fund bought 7,965 shares of the company’s stock, valued at approximately $698,000.

Other hedge funds have also added to or reduced their stakes in the company. CYBER HORNET ETFs LLC purchased a new position in shares of Revvity in the 2nd quarter worth $32,000. MUFG Securities EMEA plc purchased a new position in Revvity in the second quarter worth about $34,000. CVA Family Office LLC grew its stake in shares of Revvity by 79.0% during the 2nd quarter. CVA Family Office LLC now owns 410 shares of the company’s stock valued at $40,000 after purchasing an additional 181 shares during the period. Headlands Technologies LLC purchased a new stake in shares of Revvity during the 2nd quarter valued at about $49,000. Finally, Quent Capital LLC purchased a new stake in shares of Revvity during the 3rd quarter valued at about $71,000. 86.65% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on RVTY shares. TD Cowen restated a “hold” rating on shares of Revvity in a research report on Tuesday. Guggenheim assumed coverage on shares of Revvity in a research note on Wednesday, October 15th. They set a “neutral” rating on the stock. Evercore ISI upped their price objective on Revvity from $112.00 to $118.00 and gave the stock an “outperform” rating in a research note on Tuesday. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Revvity in a report on Monday, December 29th. Finally, Jefferies Financial Group boosted their price target on Revvity from $100.00 to $105.00 and gave the company a “hold” rating in a report on Monday. Five equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $113.67.

Revvity Stock Performance

RVTY opened at $103.60 on Thursday. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.44 and a current ratio of 1.68. The stock has a market capitalization of $11.75 billion, a price-to-earnings ratio of 49.81, a PEG ratio of 2.14 and a beta of 1.07. The company has a fifty day moving average of $103.97 and a 200 day moving average of $95.63. Revvity Inc. has a fifty-two week low of $81.36 and a fifty-two week high of $124.10.

Revvity (NYSE:RVTY) last released its quarterly earnings data on Monday, February 2nd. The company reported $1.70 EPS for the quarter, beating the consensus estimate of $1.55 by $0.15. The business had revenue of $772.06 million during the quarter, compared to the consensus estimate of $759.81 million. Revvity had a net margin of 8.45% and a return on equity of 7.92%. The business’s revenue was up 5.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.42 EPS. Revvity has set its FY 2026 guidance at 5.350-5.450 EPS. As a group, sell-side analysts forecast that Revvity Inc. will post 4.94 earnings per share for the current fiscal year.

Revvity Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 8th. Shareholders of record on Friday, April 17th will be paid a $0.07 dividend. The ex-dividend date of this dividend is Friday, April 17th. This represents a $0.28 dividend on an annualized basis and a yield of 0.3%. Revvity’s payout ratio is presently 13.46%.

Revvity announced that its board has initiated a share buyback plan on Monday, October 27th that allows the company to buyback $1.00 billion in outstanding shares. This buyback authorization allows the company to reacquire up to 8.7% of its shares through open market purchases. Shares buyback plans are typically an indication that the company’s leadership believes its shares are undervalued.

Revvity Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.